Skip to main content
. 2022 Aug 30;25:101525. doi: 10.1016/j.tranon.2022.101525

Fig. 5.

Fig 5

Differential expression and survival analysis of E2F7 (A) Expression of E2F7 in tumor samples and paired normal tissues. (B) Expression of E2F7 in different pathologic stages, histologic grades, and metastasis statuses. (C) Kaplan–Meier survival curve of OS for KIRC patients in different pathologic stages (ns: not significant, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001).